Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

Charles Craddock, Myriam Labopin, Srinivas Pillai, +15

Leukemia

Hematological MalignancyTransplantationMarrow TransplantationMedicineMixed-phenotype Acute Leukemia +9

Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects

Angela Scherwath, Anja Mehnert, B. Schleimer, +8

Annals of Oncology

Neuro-oncologyNeuropsychologyCancer LiteracyPsychiatryStandard-dose Chemotherapy +7

Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia

Nicolaus Kr�ger, M. Bornh�user, Gerhard Ehninger, +9

Annals of Hematology

Fludarabine/busulfan-based Reduced-intensity ConditioningHematological MalignancyTransplantationMarrow TransplantationMyelodysplastic Syndrome +7

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

Avichai Shimoni, Nicolaus Kröger, Tatjana Zabelina, +8

Leukemia

Unrelated DonorsTransplantationMarrow TransplantationElderly PatientsGeriatrics +9

Hepatocytic gene expression in cultured rat mesenchymal stem cells

Claudia Lange, Philipp Bassler, Michael Lioznov, +4

Transplantation Proceedings

Regenerative MedicineMedicineLiver PhysiologyAdult Stem CellStem Cell Research +7

Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias

Avichai Shimoni, Nicolaus Kröger, A R Zander, +6

Leukemia

Hematological MalignancyPhiladelphia-positive Acute LeukemiasTransplantationMarrow TransplantationDonor Lymphocyte Infusions +10

High-Dose Chemotherapy With Autologous Hematopoietic Stem-Cell Support Compared With Standard-Dose Chemotherapy in Breast Cancer Patients With 10 or More Positive Lymph Nodes: First Results of a Randomized Trial

A R Zander, Nicolaus Kröger, Claudia Schmoor, +17

Journal of Clinical Oncology

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial

Tapani Ruutu, Liisa Volin, Dietrich W. Beelen, +20

Haematologica

Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation

Joachim Dahlke, Nicolaus Kröger, Tatjana Zabelina, +12

Bone Marrow Transplantation

Hematological MalignancyTransplantationMarrow TransplantationHealth SciencesStem Cell Transplantation +7

Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program

Kai Hübel, Maximilian M. Fresen, Hans Salwender, +24

Bone Marrow Transplantation

MedicinePharmacologyPoor MobilizersPharmacotherapyMetronomic Chemotherapy +3